These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20387011)

  • 1. Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes.
    Sakly W; Mankaï A; Sakly N; Thabet Y; Achour A; Ghedira-Besbes L; Jeddi M; Ghedira I
    Endocr Pathol; 2010 Jun; 21(2):108-14. PubMed ID: 20387011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Saccharomyces cerevisiae antibodies in coeliac disease.
    Toumi D; Mankaï A; Belhadj R; Ghedira-Besbes L; Jeddi M; Ghedira I
    Scand J Gastroenterol; 2007 Jul; 42(7):821-6. PubMed ID: 17558905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus.
    Mankaï A; Sakly W; Thabet Y; Achour A; Manoubi W; Ghedira I
    Rheumatol Int; 2013 Mar; 33(3):665-9. PubMed ID: 22527140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti Saccharomyces cerevisiae Antibodies in Patients With Anti-β2 Glycoprotein I Antibodies.
    Mankaï A; Layouni S; Ghedira I
    J Clin Lab Anal; 2016 Nov; 30(6):818-822. PubMed ID: 27061484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Saccharomyces cerevisiae antibodies are elevated in Graves' disease but not in Hashimoto's thyroiditis.
    Mankaï A; Thabet Y; Manoubi W; Achour A; Sakly W; Ghedira I
    Endocr Res; 2013; 38(2):98-104. PubMed ID: 22992126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet.
    Mallant-Hent RCh; Mary B; von Blomberg E; Yüksel Z; Wahab PJ; Gundy C; Meyer GA; Mulder CJ
    Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):75-8. PubMed ID: 16357623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.
    Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM
    Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis.
    Sakly W; Jeddi M; Ghedira I
    Dig Dis Sci; 2008 Jul; 53(7):1983-7. PubMed ID: 18049897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASCA (Anti-Saccharomyces cerevisiae Antibody) in Patients With Scleroderma.
    Fedrigo A; Skare TL; Bortoluzzi AL; Nisihara R
    J Clin Rheumatol; 2019 Jan; 25(1):24-27. PubMed ID: 29561467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
    Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G
    Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.
    Russell RK; Ip B; Aldhous MC; MacDougall M; Drummond HE; Arnott ID; Gillett PM; McGrogan P; Weaver LT; Bisset WM; Mahdi G; Wilson DC; Satsangi J
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):161-7. PubMed ID: 19179877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome.
    Fresko I; Ugurlu S; Ozbakir F; Celik A; Yurdakul S; Hamuryudan V; Yazici H
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S67-70. PubMed ID: 16273768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Saccharomyces cerevisiae Antibodies in Rheumatoid Arthritis.
    Melayah S; Ghozzi M; Jemni M; Sakly N; Ghedira I; Mankaï A
    Lab Med; 2022 Nov; 53(6):585-589. PubMed ID: 35699491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
    Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
    Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the relationship between anti-Helicobacter pylori and anti-Saccharomyces cerevisiae antibodies in patients with axial spondyloarthritis and Crohn disease.
    Rodrigues IK; Andrigueti M; de Oliveira Gil ID; de Lucca Schiavon L; de Andrade KR; Pereira IA; de Castro GR; Zimmermann AF; Saporiti LN; Bazzo ML; Neves FS
    Rheumatol Int; 2015 Feb; 35(2):359-66. PubMed ID: 25119827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.
    Hoffman IE; Demetter P; Peeters M; De Vos M; Mielants H; Veys EM; De Keyser F
    Ann Rheum Dis; 2003 May; 62(5):455-9. PubMed ID: 12695160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Saccharomyces cerevisiae antibodies in acute myocardial infarction.
    Cinemre H; Bilir C; Gokosmanoglu F; Kadakal F
    J Investig Med; 2007 Dec; 55(8):444-9. PubMed ID: 18163971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease.
    Kotze LM; Nisihara RM; Utiyama SR; Kotze PG; Theiss PM; Olandoski M
    Arq Gastroenterol; 2010; 47(3):242-5. PubMed ID: 21140083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.